It is our pleasure to welcome you to the 1st Edition Annual Congress On Vaccines and Vaccination: R & D the Vaccines Congress 2019 Special Conference builds on the hugely successful preceding conferences, hosted by the SciTech Conferences (STC).

 

The Vaccines Congress 2019 includes 40+ plenary lectures, dedicated poster sessions and interactive elements. The medium-large size of the conference makes it an excellent forum to share new data, and to network with colleagues and speakers.

Details of Vaccines and Vaccination Congress 2019 in Tokyo, Japan:

Conference Name Place Date
Annual Congress On Vaccines and Vaccination: R & D Tokyo, Japan September 09-10, 2019

 

Global Vaccines Market was valued at $32,215 million in 2017, and is expected to reach $66,148 million in 2023, and register a CAGR of 11.9%, during the forecast period, 2017‐ 2023. Vaccine is a biological preparation that is administered to produce acquired immunity in patients. Administration of vaccines aids to enhance the immune response against a specific pathogen.

 

By disease indication, the vaccines market is segmented into pneumococcal disease, influenza, DTP, hepatitis, human papillomavirus (HPV), rotavirus, meningococcal disease, MMR (measles, mumps, and rubella), varicella, polio, herpes zoster, dengue, and other disease indications. The meningococcal segment is expected to register the highest rate during the forecast period. The growth in this segment can primarily be attributed to the increasing government investments in meningococcal vaccination programs and high prevalence of meningococcal disease.

 

(99% of participants would recommend the conference to a colleague).

Vaccines Market, By Technology

 

By Type / By Patient Type

 

By Route of Administration

 

  • Conjugate Vaccines
  • Inactivated and Subunit Vaccines
  • Live Attenuated Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • Monovalent Vaccines
  • Multivalent Vaccines

 

  • Pediatrics
  • Adults
  • Intramuscular and Subcutaneous Administration
  • Oral Administration
  • Other Routes of Administration

 

By Disease Indication

 

By Region

 

  • Pneumococcal Disease
  • Influenza
  • DTP
  • Hepatitis
  • Human Papilloma Virus (HPV)
  • Rotavirus
  • Meningococcal Disease
  • MMR (measles, mumps, and rubella)
  • Varicella
  • Polio
  • Herpes Zoster
  • Dengue
  • Other Disease Indications
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia
    • Japan
    • China
    • India
    • Rest of Asia (RoA)
  • Rest of the World (RoW)

 

Facebook By Weblizar Powered By Weblizar

45+ Speakers

100+ Delegates

 

Events Starts in

110Days 03Hours 12Minutes 37Seconds

Scientific Committee

Professor Md.Tanvir Rahman
DVM, MSc (Canada), PhD (UK), Postdoc (Germany)
Bangladesh Agricultural University

Jennifer Jones

New South Wales. Australia

Pierre A. MORGON

CEO & Founder MRGN Advisors Switzerland

Dr Matthias Giese

CEO & Founder Institute for Molecular Vaccines Germany

Dr Rakesh Srivastava

President & CEO Medisoft Inc. USA

Speakers

Professor Md.Tanvir Rahman
DVM, MSc (Canada), PhD (UK), Postdoc (Germany)
Bangladesh Agricultural University

Dr Linda Girgis
Director
Girgis Family Medicine LLC
USA

Pierre A. MORGON

CEO & Founder MRGN Advisors Switzerland

Dr Matthias Giese

CEO & Founder Institute for Molecular Vaccines Germany

Dr Rakesh Srivastava

President & CEO Medisoft Inc. USA

Media Partners, Collaborators & Sponsors

View More

Conference Venue: International Garden Hotel Narita